High prevalence of constipation and reduced quality of life in opioid-dependent patients treated with opioid substitution treatments. (1st November 2016)
- Record Type:
- Journal Article
- Title:
- High prevalence of constipation and reduced quality of life in opioid-dependent patients treated with opioid substitution treatments. (1st November 2016)
- Main Title:
- High prevalence of constipation and reduced quality of life in opioid-dependent patients treated with opioid substitution treatments
- Authors:
- Lugoboni, Fabio
Mirijello, Antonio
Zamboni, Lorenzo
Faccini, Marco
Casari, Rebecca
Cossari, Anthony
Gasbarrini, Antonio
Addolorato, Giovanni
on behalf of GICS, - Abstract:
- ABSTRACT: Objectives To evaluate prevalence and severity of constipation and quality of life (QoL) in a cohort of opioid-addicted patients treated with opioid substitution treatments (OST). Methods : A total of 1057 heroin-dependent patients treated with methadone or buprenorphine were enrolled in a multicenter observational study. Constipation was assessed by Wexner Constipation Scoring System (Wexner CSS), QoL by General Health Questionnaire (GHQ-12). Results : 38.5% patients reported mild constipation, 33.3% reported moderate constipation, 14.8% severe constipation and 5.1% very severe constipation. Mean Wexner CSS score was 6.6 ± 4.8. 44.9% patients showed a GHQ-12 score ≥14; of these 18.3% patients showed a GHQ-12 score ≥20. Mean GHQ score was 13.8 ± 6.5. Mean Wexner CSS score was significantly higher in methadone patients (p = 0.004), in those taking psychoactive drugs (p = 0.0001) and in female (p < 0.0001) with respect to counterparts. Similarly, GHQ-12 mean scores were higher methadone group (p = 0.003), in those taking psychoactive drugs (p < 0.0001), and in female (p = 0.039) with respect to counterparts. ANOVA and ANCOVA showed a significant influence of methadone and female gender on Wexner CSS score while psychoactive drugs significantly influenced both tests. Conclusions : The present study shows that patients affected by opioid-dependence in OST with methadone and buprenorphine have a high prevalence of constipation and reduced QoL.
- Is Part Of:
- Expert opinion on pharmacotherapy. Volume 17:Number 16(2016)
- Journal:
- Expert opinion on pharmacotherapy
- Issue:
- Volume 17:Number 16(2016)
- Issue Display:
- Volume 17, Issue 16 (2016)
- Year:
- 2016
- Volume:
- 17
- Issue:
- 16
- Issue Sort Value:
- 2016-0017-0016-0000
- Page Start:
- 2135
- Page End:
- 2141
- Publication Date:
- 2016-11-01
- Subjects:
- Constipation -- opioid induced constipation -- opioid induced bowel dysfunction -- opioid substitution treatment -- methadone -- buprenorphine
Chemotherapy -- Periodicals
615.5805 - Journal URLs:
- http://informahealthcare.com/ ↗
http://www.tandfonline.com/toc/ieop20/current ↗
http://informahealthcare.com ↗
http://titania.ashley-pub.com/vl=5663459/cl=52/nw=1/rpsv/journal/journal6_home.htm ↗ - DOI:
- 10.1080/14656566.2016.1232391 ↗
- Languages:
- English
- ISSNs:
- 1465-6566
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3842.002956
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 2588.xml